PETER JINDRA to HLA Antigens
This is a "connection" page, showing publications PETER JINDRA has written about HLA Antigens.
Connection Strength
2.061
-
Human Leukocyte Antigen Epitope Matching in Solid Organ Transplantation. Clin Lab Med. 2018 12; 38(4):595-605.
Score: 0.543
-
HLA class I antibody-mediated endothelial cell proliferation via the mTOR pathway. J Immunol. 2008 Feb 15; 180(4):2357-66.
Score: 0.260
-
Anti-HLA antibodies can induce endothelial cell survival or proliferation depending on their concentration. Transplantation. 2006 Jul 15; 82(1 Suppl):S33-5.
Score: 0.233
-
Virtual crossmatching: Principles, practices, and the path forward-An American Society for Histocompatibility and Immunogenetics/College of American Pathologists collaborative. Am J Transplant. 2025 Oct; 25(10):2048-2056.
Score: 0.216
-
Reducing number of laboratories performing complement dependent cytotoxicity crossmatching: Reasons and conclusions. Hum Immunol. 2022 May; 83(5):467-475.
Score: 0.171
-
Minimal data reporting standards for serological testing for histocompatibility. Hum Immunol. 2018 Dec; 79(12):865-868.
Score: 0.134
-
Glomerulocapillary miRNA response to HLA-class I antibody in vitro and in vivo. Sci Rep. 2017 11 06; 7(1):14554.
Score: 0.127
-
Analysis of a Genetic Polymorphism in the Costimulatory?Molecule TNFSF4 with Hematopoietic Stem?Cell?Transplant Outcomes. Biol Blood Marrow Transplant. 2016 Jan; 22(1):27-36.
Score: 0.110
-
Impact of in vivo T-cell depletion on outcome of AML patients in first CR given peripheral blood stem cells and reduced-intensity conditioning allo-SCT from a HLA-identical sibling donor: a report from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant. 2014 Mar; 49(3):389-96.
Score: 0.098
-
Anti-HLA class I antibody-mediated activation of the PI3K/Akt signaling pathway and induction of Bcl-2 and Bcl-xL expression in endothelial cells. Hum Immunol. 2004 Apr; 65(4):291-302.
Score: 0.050
-
Rare variants and HLA haplotypes associated in patients with neuromyelitis optica spectrum disorders. Front Immunol. 2022; 13:900605.
Score: 0.045
-
Optimal Donor Selection During Verification Process: Which Factors Are Worth Knowing? Transplant Proc. 2018 Dec; 50(10):3082-3087.
Score: 0.034
-
A prospective registration study to determine feasibility of hematopoietic SCT in adults with acute leukemia: planning, expectations and reality. Bone Marrow Transplant. 2014 Mar; 49(3):376-81.
Score: 0.024
-
Association of IL6 and CCL2 gene polymorphisms with the outcome of allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplant. 2009 Aug; 44(4):227-35.
Score: 0.017